The Imperative of Clinical Trial Diversity: Lessons From the SARS-CoV-2 Pandemic

The National Academy of Science, Engineering, and Medicine recently published a report on the lack of diversity in clinical trials.1 This concern, highlighting the importance of research equity, proved especially relevant during the COVID-19 pandemic.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Tags: Letter to the Editor Source Type: research